http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100485249-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-34 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-34 |
filingDate | 1997-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2005-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-100485249-B1 |
titleOfInvention | Remedy for erection failure comprising fused pyridazine compound |
abstract | Provides a treatment for erectile dysfunction. The active ingredient is represented by the formula (I).n n n Formula In n n n n n n n Wherein ring C means an aromatic 5-6 membered ring which may have a hetero atom, n means an integer of 1-4, R 1 represents a hydrogen atom, a halogen atom, a cyano group, and A represents a hydrogen atom , A halogen atom, an amino group which may have a substituent, and the like, X represents a group represented by the formula -N =, Y represents a formula -CO-, an amino group which may have a substituent, and the like. Minced compound or a pharmacologically acceptable salt thereof. |
priorityDate | 1996-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.